Life in the Nesac Market site in the heart of New York City's Times Square, this is fast money.

Here's what's on tap tonight. A big beat for Disney. The company major gains a theme parks, a sharp rise in streaming

subscribers and billions more in cost cutting than expected,

but will it be enough to offset the ad declines in legacy media?

We'll debate that. Plus, obesity breakthrough, the FDA approving Eli Lilly's blockbuster drug

Munjaro for weight loss, paving the way for a pop and prescriptions, the

details in the impact for the sector coming up. And later the Chartmaster is

here with a new call on crude and energy stocks will give us a long

and short of his technical take straight ahead.

I'm Melissa Lee coming to you live from Studio B at the Nasak on the desk tonight.

Steve Brasso, Carter Worth, Guyadami, and Julie Beal.

We start off with Disney earnings shares of the entertainment giant slightly higher in the

after hours, beating earnings estimates and raising its cost-cutting target revenues.

Though, did fall short of expectations.

CNB.

Julie Morrison spoke with CEO Bob I earned just the last hour about the quarter and the future of

ESPN and much more.

Julia, what's the latest? Well, Melissa, Disney reporting a big beat in earnings,

thanks to expanding its cost-cutting target by $2 billion to $7.5 billion,

the company also dramatically reducing its losses in its direct-to-consumer

division, while its subscribers in that division were a big beat.

CEO Bob Eiger, announcing in our interview that they are launching a beta test of Disney Plus integrated

...